The 100 kilodalton common acute lymphoblastic leukaemia antigen (CALLA, gplOO) was first defined by means of xenoantisera. ' Regarded as a probable marker for early lymphoid progenitor cells, CALLA was soon detected on a minority population of normal bone marrow precursor cells2 which express the phenotype of common acute lymphoblastic leukaemia.3 CALLA is therefore now regarded as a transiently expressed stem cell antigen, immortalised on leukaemic cells as part of their expression of a "frozen' neoplastic phenotype. 23 With the advent of monoclonal anti-CALLA antibodies4-7 it became clear that CALLA was not restricted to cells of lymphoid lineage: CALLA has now been shown on polymorphonuclear neutrophils,8 granulocytes,9 kidney tubular epithelium, glomeruli and breast myoepithelium,'°melanoma" glioma cells,'2 and cultured fibroblasts.9
Accepted for publication 16 May 1985 In view of the known characteristic reactivity of anti-CALLA antibodies on the brush border of kidney epithelium'°we aimed to investigate the expression of antigens like CALLA by the enterocytes of the small intestine as a correlate of mucosal damage associated with conditions such as coeliac disease. The specialised columnar epithelium cells of the jejunum are characterised by a microvillous brush border on the luminal (apical) surface and play a vital part in the absorption of nutrients, probably through several enzymatic and passive and active transport mechanisms.'3 In coeliac disease severe malabsorption is accompanied by profound morphological change of the jejunal mucosa: the villi are shorter and broader and may be entirely absent, whereas the epithelial cells become cuboidal rather than columnar and the microvilli are shorter and less regular. '4-'6 Other antigens associated with eukaemia:
Immunofluorescence reaction was scored subjectively from negative (-) to strong positive (+++). The 10 monoclonal antibodies to antigens associated with leukaemia used in this study are listed in the Table. Eight of these antibodies were specific to the 100 kilodalton (gplOO) CALLA antigen. The three RFAL anti-CALLA antibodies were obtained after fusion, induced by polyethylene glycol, '9 of splenocytes from mice immunised with the NALM-6 common acute lymphoblastic leukaemia cell line20 with NSO/1 plasmacytoma cells. '9 Hybrid clones were initially screened by immunofluorescence on sections of tissue and subsequently characterised by flow cytofluorimetry. Two non-CALLA antibodies raised to leukaemic cells were also included for control purposes-namely, antibodies BA-25 and AL1,2' which react with antigens associated with leukaemia of 24 and 120 kilodaltons, respectively.
CALLA e-xpression in jejunal brush border Trejdosiewicz, Malizia, Oakes, Losowsky, Janossy. The immunofluorescence reaction was performed as previously described. 22 
Results

NORMAL JEJUNUM
The eight CALLA antibodies gave a characteristic and specific reaction with the brush border of small intestine epithelium of fetal and adult specimens (Fig. 1) . Of the antibody panel, only AL1 and BA-2 antibodies to non-CALLA (gplOO) antigens with associated leukaemia were negative (Table) . The reaction of the anti-CALLA antibodies were unequivocal, ranging in intensity from moderate to strong on fetal and adult jejunum. In adult specimens of normal histology (grade 1) the reaction was equally positive on crypt and villous epithelium. In the fetal small intestine all antibodies except ALl and BA-2 reacted strongly with enterocytes, although there was a cytoplasmic reaction in some crypt cells, rather than the brush border reaction characteristic of adult jejunal epithelium.
COELIAC DISEASE
In patients with coeliac disease in whom there was profound histological abnormality (grades 3 and 4) seven anti-CALLA antibodies were still positive with all epithelial cells, although there was a slight tendency for a weaker reaction with the non-crypt luminal surface epithelium with RFAL-3, J5, BA-3, BD-CALLA, and VIL-1A (Table) .
Whereas in normal jejunum RFAL-2 reacted strongly with the entire villous and crypt epithelium (Fig. 1) , in biopsies of patients with untreated coeliac disease of grade 4 histology RFAL-2 reactivity was diminished in the crypts and either weak or absent from the remaining luminal epithelium (Fig.  4) . In the patients with treated coeliac disease, ranging in morphology from grade 1 (normal) to grade 3 (severe villous atrophy), RFAL-2 labelling was closely related to the pathological change and degree of atrophy present, almost certainly as a function of the date a gluten free diet was started and strictness of adherence to the diet: the less severe the pathological villous atrophy the stronger the reaction of RF-CALLA along the vili and the more it resembled the normal jejunal pattern. Thus in well treated patients with grade 1 histology the reactivity pattern was the same as in normal 1005 jejunum, whereas in poorly treated patients (grades 2 and 3) there was much less reactivity on the stunted villi, with a strong reaction observed only in the crypts (Figs. 2 and 3 ).
STOMACH AND LARGE BOWEL
All antibodies, including the eight anti-CALLA antibodies, were essentially negative on cryostat sections of normal stomach (antrum and body). There was no reaction of anti-CALLA antibodies with the fetal large bowel epithelium or adult large bowel epithelium from patients with normal histology or patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
Discussion
Our results clearly show the strong expression of a moeity related to CALLA in the brush border of normal jejunal epithelium. The essentially negative reaction of anti CALLA antibodies in stomach epithelium and the totally negative reaction in colonic epithelium imply a functional role for the entity similar to common acute lymphoblastic leukaemia expressed in normal jejunal epithelium, related to the functional capacity of these cells. Notwithstanding the clinical implications for direct immunotherapy with anti-CALLA monoclonal antibodies to remove residual leukaemic cells,26 the finding that anti-CALLA antibodies react with normal jejunal epithelium suggests that such antibodies may be useful probes for the study of absorbtive intestinal enterocytes. Especially useful in this context would be the antibody RFAL-2 in view of its apparent ability to discriminate normal from damaged jejunal epithelium.
The functional importance of the 90-100 kilodalton (gplOO) CALLA entity, either on common acute lymphoblastic leukaemia cells or on their normal haemopoietic cell progenitors, is not clear. Possibly, CALLA may be involved in absorptive processes, given its strong expression by kidney epithelium. ' 
